Market Tracker

10/23 3:45am ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.87
Delayed Data
As of Oct 20
 +0.01 / +0.26%
Today’s Change
2.67
Today|||52-Week Range
5.10
+44.94%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.86
Today’s open3.91
Day’s range3.86 - 3.91
Volume29,977
Average volume (3 months)151,122
Market cap$202.7M
Dividend yield--
Data as of 10/20/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-89.73%
P/E ratioNM
Price/Sales434.52
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MGENMiragen Therapeutics...+0.44+4.90%
FOMXFoamix Pharmaceutica...+0.31+4.76%
KURAKura Oncology Inc-0.30-2.08%
ATHXAthersys Inc+0.15+8.15%
Data as of 4:00pm ET, 10/20/2017

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$283.6K
Annual profit (last year)-$13.1M
Net profit margin-4,622.39%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts